October 26, 2016 5:09 AM ET


Company Overview of Tobira Therapeutics, Inc.

Key Executives for Tobira Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Laurent Fischer M.D.70 RelationshipsChief Executive Officer and Director52
Eckard Weber M.D.44 RelationshipsFounder, Director and Member of Nominating & Governance Committee66
Christopher Peetz No RelationshipsChief Financial Officer and Head of Corporate Development37
Helen Jenkins MANo RelationshipsChief Operating Officer52
Eric A. Lefebvre M.D.No RelationshipsChief Medical Officer52

Tobira Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Dennis G. Podlesak MBA 38 RelationshipsDomain Associates, L.L.C.58
Laurent Fischer M.D. 70 RelationshipsTobira Therapeutics, Inc.52
Eckard Weber M.D. 44 RelationshipsOcera Therapeutics, Inc.66
Jeffrey H. Cooper MBA, CPA 18 RelationshipsProNAi Therapeutics, Inc.60
Pierre Legault CA, MBA, CPA 46 RelationshipsPoxel SA55
View All Board Members

Tobira Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CA, MBA, CPAPierre Legault46 Relationships3 Executives
Compensation Committee Andrew J. Fromkin22 Relationships4 Executives
Nominating Committee MBA, CPAJeffrey H. Cooper18 Relationships4 Executives
Corporate Governance Committee MBA, CPAJeffrey H. Cooper18 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$460.9K
Total Value of Options
Compensation as of Fiscal Year
Tobira Therapeutics, Inc. CEO Compensation
Industry Average


Global Blood Therapeutics, Inc. Announces Resignation of Dr. Eleanor Ramos as Chief Medical Officer
October 24, 2016 8:34 PM ET
GenVec, Inc. Announces Board Changes
October 24, 2016 8:33 PM ET
Gradalis, Inc. Appoints Brian Daniels to its Scientific Advisory Board
October 24, 2016 4:19 PM ET
OncBioMune Pharmaceuticals, Inc. Appoints Brian Barnett to its Scientific Advisory Board
October 24, 2016 2:47 PM ET
Stellar Biotechnologies, Inc. Appoints Gregory T. Baxter as Vice President of Corporate Development and Communications, Effective December 1, 2016
October 24, 2016 11:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tobira Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.